HK1085643A1 - Uses and compositions for administration of capsaicin - Google Patents
Uses and compositions for administration of capsaicinInfo
- Publication number
- HK1085643A1 HK1085643A1 HK06107501.1A HK06107501A HK1085643A1 HK 1085643 A1 HK1085643 A1 HK 1085643A1 HK 06107501 A HK06107501 A HK 06107501A HK 1085643 A1 HK1085643 A1 HK 1085643A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- capsaicin
- administration
- compositions
- Prior art date
Links
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 title 2
- 229960002504 capsaicin Drugs 0.000 title 1
- 235000017663 capsaicin Nutrition 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46204003P | 2003-04-10 | 2003-04-10 | |
US46245703P | 2003-04-10 | 2003-04-10 | |
US49906203P | 2003-08-29 | 2003-08-29 | |
PCT/US2004/011336 WO2004091521A2 (en) | 2003-04-10 | 2004-04-12 | Methods and compositions for administration of trpv1 agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1085643A1 true HK1085643A1 (en) | 2006-09-01 |
Family
ID=33303907
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06107501.1A HK1085643A1 (en) | 2003-04-10 | 2006-07-03 | Uses and compositions for administration of capsaicin |
HK16101869.8A HK1213802A1 (zh) | 2003-04-10 | 2016-02-19 | 施用 激動劑的方法和組合物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16101869.8A HK1213802A1 (zh) | 2003-04-10 | 2016-02-19 | 施用 激動劑的方法和組合物 |
Country Status (8)
Country | Link |
---|---|
US (6) | US7943166B2 (ja) |
EP (2) | EP2907503A1 (ja) |
JP (6) | JP4931128B2 (ja) |
CA (1) | CA2522028C (ja) |
EA (1) | EA012599B1 (ja) |
ES (1) | ES2535045T3 (ja) |
HK (2) | HK1085643A1 (ja) |
WO (1) | WO2004091521A2 (ja) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7943166B2 (en) | 2003-04-10 | 2011-05-17 | Neurogesx, Inc. | Methods and compositions for administration of TRPV1 agonists |
JP2006151971A (ja) * | 2004-11-05 | 2006-06-15 | Maruishi Pharmaceutical Co Ltd | インスリン様成長因子−1分泌促進剤 |
WO2006066419A1 (de) * | 2004-12-22 | 2006-06-29 | Mestex Ag | Mischung eines vanilloidrezeptoragonisten mit einer nervenregenerationshemmenden substanz, ihre verwendung für die herstellung eines schmerzmittels und verfahren zur applikation dieses mittels |
ZA200707492B (en) * | 2005-02-14 | 2009-02-25 | Neurogesx Inc | Device for delivery of TRPV1 agonists |
US20060222690A1 (en) * | 2005-03-30 | 2006-10-05 | Bley Keith R | Low-concentration capsaicin patch and methods for treating neuropathic pain |
GB0509573D0 (en) * | 2005-05-11 | 2005-06-15 | Merck Sharp & Dohme | Therapeutic compounds |
EP1933813A4 (en) * | 2005-10-11 | 2013-02-27 | Univ Pittsburgh | SPHINGOMYELIN LIPOSOME FOR THE TREATMENT OF HYPERACTIVE BLADDER DISORDER |
WO2007102241A1 (ja) | 2006-03-08 | 2007-09-13 | Nihon Nohyaku Co., Ltd. | 外用の医薬組成物 |
CA2645070C (en) | 2006-03-08 | 2014-02-04 | Nihon Nohyaku Co., Ltd. | Pharmaceutical composition for external use |
US20070233211A1 (en) * | 2006-04-04 | 2007-10-04 | Galer Bradley S | Methods and compositions for treating non-neuropathic pain |
US7943666B2 (en) * | 2006-07-24 | 2011-05-17 | Trinity Laboratories, Inc. | Esters of capsaicin for treating pain |
US20080038377A1 (en) * | 2006-08-09 | 2008-02-14 | Citow Jonathan S | Device for treatment of inflamed tissue |
US20080095720A1 (en) * | 2006-10-18 | 2008-04-24 | Conopco, Inc., D/B/A Unilever | Skin Benefit Compositions with a Vanilloid Receptor Antagonist |
JP2010510227A (ja) | 2006-11-20 | 2010-04-02 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | 痛みおよび痒みの治療方法、組成物およびキット |
WO2008095297A1 (en) | 2007-02-06 | 2008-08-14 | Origin Biomed Inc. | Composition comprising terpene compounds and methods for inhibiting nerve transmission |
JPWO2008111296A1 (ja) * | 2007-03-09 | 2010-06-24 | 国立大学法人京都大学 | 角化の亢進に起因する皮膚疾患の予防及び治療のための医薬 |
US20090197819A1 (en) * | 2007-03-20 | 2009-08-06 | Clarence Albert Johnson | Compositions for improving and repairing skin |
US20080312169A1 (en) * | 2007-03-20 | 2008-12-18 | Clarence Albert Johnson | Cosmetic use of D-ribose |
WO2009026178A2 (en) * | 2007-08-17 | 2009-02-26 | Arcion Therapeutics, Inc. | High concentration local anesthetic formulations |
JP5345937B2 (ja) | 2007-09-05 | 2013-11-20 | 株式会社ポーラファルマ | 抗真菌組成物 |
ES2591030T3 (es) | 2007-09-05 | 2016-11-24 | Pola Pharma Inc. | Composición farmacéutica antifúngica |
ES2430043T3 (es) * | 2007-11-19 | 2013-11-18 | Nestec S.A. | Tratamiento de la disfagia faríngea oral |
WO2009114139A2 (en) * | 2008-03-11 | 2009-09-17 | President And Fellows Of Harvard College | Methods, compositions, and kits for treating pain and pruritis |
US20090232750A1 (en) * | 2008-03-13 | 2009-09-17 | St Cyr John A | Compositions for indoor tanning |
US9415023B2 (en) | 2008-08-13 | 2016-08-16 | Neuroquest Inc. | Compositions comprising terpene compounds for treating negative sensory phenomena |
US8119694B2 (en) | 2008-08-15 | 2012-02-21 | Arcion Therapeutics, Inc. | High concentration local anesthetic formulations |
DK2349201T3 (en) * | 2008-10-30 | 2015-01-19 | Medlite As | Formulation for the treatment of vaginal dryness |
IL196695A (en) * | 2009-01-25 | 2015-10-29 | Secret Of Youth Ltd | Preparations containing fruit and vegetable derivatives and their uses |
DE102009013469B4 (de) * | 2009-03-19 | 2014-04-17 | Bubbles And Beyond Gmbh | Zubereitung zur äußerlichen Anwendung |
JP5688406B2 (ja) * | 2009-04-09 | 2015-03-25 | 株式会社ポーラファルマ | 抗真菌医薬組成物 |
EP2416757A2 (en) | 2009-04-09 | 2012-02-15 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
CA2761156C (en) * | 2009-05-07 | 2017-03-14 | University Of Cincinnati | Methods of preventing ischemic injury using peripheral nociceptive stimulation |
US20110077512A1 (en) * | 2009-06-16 | 2011-03-31 | Dept. Of Veterans Affairs | Biopsy marker composition and method of use |
WO2011006073A1 (en) | 2009-07-10 | 2011-01-13 | President And Fellows Of Harvard College | Permanently charged sodium and calcium channel blockers as anti-inflammatory agents |
KR101754697B1 (ko) | 2009-08-25 | 2017-07-06 | 가부시키가이샤 폴라 파마 | 항진균성 약제학적 조성물 |
JP2012208526A (ja) * | 2009-09-02 | 2012-10-25 | Sony Corp | 光学素子、および表示装置 |
EP2579847A1 (en) * | 2010-06-11 | 2013-04-17 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
ES2700213T3 (es) * | 2010-11-08 | 2019-02-14 | Epitech Group S P A | Preparación farmacológica para uso tópico que contiene N-palmitoil-vainillamida |
US20120253143A1 (en) * | 2011-04-04 | 2012-10-04 | Raphael Warren | Method of measuring a skin agent transferred to skin |
BR112014005358A8 (pt) | 2011-09-09 | 2017-10-03 | Propella Therapeutics Inc | Composições compreendendo agonista seletivo de trpv1 e seus usos |
KR101338521B1 (ko) * | 2011-11-04 | 2013-12-10 | 고려대학교 산학협력단 | 만성 가려움증 또는 아토피성 피부염 유발 쥐 및 이를 이용한 치료용 화합물의 스크리닝 방법 |
US9211274B2 (en) * | 2012-02-01 | 2015-12-15 | Warsaw Orthopedic, Inc. | TRPV1 compounds in a biodegradable polymer carrier |
EP2919773A4 (en) * | 2012-11-19 | 2016-11-02 | Univ Columbia | METHOD FOR THE TREATMENT OF KERATINOCYTE-MEDIATED LESIONS |
US9320749B2 (en) * | 2014-01-06 | 2016-04-26 | University Of Wyoming | Nanoparticle delivery system for targeted anti-obesity treatment |
KR102073258B1 (ko) | 2014-04-15 | 2020-02-04 | 비쭈리 헬스 사이언스 엘엘씨 | 통증 완화용 국소 조성물, 제조방법 및 용도 |
WO2016046817A1 (en) * | 2014-09-24 | 2016-03-31 | Vital Beverages Global Inc. | Compositions and methods for selective gi tract delivery |
EP3226972A4 (en) | 2014-12-01 | 2018-08-08 | Achelios Therapeutics, Inc. | Methods and compositions for treating migraine and conditions associated with pain |
US10300032B2 (en) | 2015-02-20 | 2019-05-28 | Osmotica Kereskedelmi Es Szolgaltato Kft | Controlled release dosage form |
EP3258916A1 (en) | 2015-02-20 | 2017-12-27 | Osmotica Kereskedelmi ES Szolgaltato KFT | Controlled release oral dosage form of gaba receptor agonist with enhanced pharmacokinetics |
US10987328B2 (en) | 2015-02-20 | 2021-04-27 | Osmotica Kereskedelmi Es Szolgaltato Kft | Controlled release dosage form |
US10172800B2 (en) | 2015-02-20 | 2019-01-08 | Osmotica Kereskedelmi Es Szolgaltato Kft | Controlled release dosage form with enhanced pharmacokinetics |
US10898537B2 (en) * | 2015-07-31 | 2021-01-26 | Delivra Inc. | Transdermal formulations for delivery of capsaicinoids |
AU2016301282B2 (en) | 2015-08-03 | 2022-03-17 | Children's Medical Center Corporation | Charged ion channel blockers and methods for use |
EP3534961A4 (en) | 2016-11-02 | 2020-05-27 | Centrexion Therapeutics Corporation | STABLE AQUEOUS INJECTABLE CAPSAICIN FORMULATIONS AND MEDICAL USES THEREOF |
CN111201015A (zh) | 2017-07-20 | 2020-05-26 | 中枢疗法公司 | 使用辣椒素治疗疼痛的方法和组合物 |
US11464858B2 (en) | 2018-06-23 | 2022-10-11 | University Of Wyoming | Magnetic nanoparticle delivery system for pain therapy |
US20200138734A1 (en) * | 2018-07-23 | 2020-05-07 | Jerry Mcshane | Topical formulation for treating bruising |
US11254659B1 (en) | 2019-01-18 | 2022-02-22 | Centrexion Therapeutics Corporation | Capsaicinoid prodrug compounds and their use in treating medical conditions |
US11447444B1 (en) | 2019-01-18 | 2022-09-20 | Centrexion Therapeutics Corporation | Capsaicinoid prodrug compounds and their use in treating medical conditions |
EP3937945A4 (en) | 2019-03-11 | 2023-01-04 | Nocion Therapeutics, Inc. | CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE |
US10828287B2 (en) | 2019-03-11 | 2020-11-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
JP2022527690A (ja) | 2019-03-11 | 2022-06-03 | ノシオン セラピューティクス,インコーポレイテッド | 荷電したイオンチャンネル遮断薬および使用方法 |
US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
MA55320A (fr) | 2019-03-11 | 2022-01-19 | Nocion Therapeutics Inc | Bloqueurs de canaux ioniques substitués par un ester et méthodes d'utilisation |
CN113227416B (zh) | 2019-03-11 | 2023-04-04 | 日本制铁株式会社 | 热轧钢板 |
WO2020222187A1 (en) * | 2019-05-01 | 2020-11-05 | Clexio Biosciences Ltd. | Finished fibrous structures and methods of their use and preparation |
WO2021035037A1 (en) * | 2019-08-20 | 2021-02-25 | Georgetown University | Method to increase systemic blood pressure in shock |
CN114828845A (zh) | 2019-11-06 | 2022-07-29 | 诺西恩医疗公司 | 带电的离子通道阻滞剂及其使用方法 |
US10933055B1 (en) | 2019-11-06 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
JP2023517604A (ja) | 2020-03-11 | 2023-04-26 | ノシオン セラピューティクス,インコーポレイテッド | 荷電したイオンチャンネル遮断薬および使用方法 |
CA3175582A1 (en) | 2020-03-17 | 2021-09-23 | Grunenthal Gmbh | Repeated topical application of capsaicin patch for treating initial non-responders |
EP4125841A1 (en) | 2020-04-03 | 2023-02-08 | Grünenthal GmbH | Regimen for repeated topical application of capsaicin patch |
CN117355312A (zh) * | 2021-03-15 | 2024-01-05 | 转位治疗股份有限公司 | 治疗cns和全身性疾病的line-1抑制剂 |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US505958A (en) * | 1893-10-03 | Register or recorder | ||
US4313958A (en) | 1980-10-24 | 1982-02-02 | The Procter & Gamble Company | Method of producing analgesia |
US4546112A (en) * | 1981-12-14 | 1985-10-08 | The Procter & Gamble Company | Method for preventing or reducing dipilatory irritation |
US4544669A (en) | 1983-07-14 | 1985-10-01 | The Procter & Gamble Company | Compounds and compositions useful for producing analgesia |
US4544668A (en) | 1983-07-14 | 1985-10-01 | The Procter & Gamble Company | Compounds and compositions useful for producing analgesia |
US4532139A (en) | 1983-07-14 | 1985-07-30 | The Procter & Gamble Company | Compounds and compositions useful for producing analgesia |
US4493848A (en) * | 1983-07-14 | 1985-01-15 | The Procter & Gamble Company | Compositions and methods useful for producing analgesia |
US4564633A (en) * | 1983-07-14 | 1986-01-14 | The Procter & Gamble Company | Compositions and methods useful for producing analgesia |
US4681897A (en) | 1984-01-16 | 1987-07-21 | The Procter & Gamble Company | Pharmaceutical products providing enhanced analgesia |
US4599342A (en) | 1984-01-16 | 1986-07-08 | The Procter & Gamble Company | Pharmaceutical products providing enhanced analgesia |
US4927687A (en) * | 1984-10-01 | 1990-05-22 | Biotek, Inc. | Sustained release transdermal drug delivery composition |
IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US4892890A (en) * | 1984-11-01 | 1990-01-09 | G. D. Searle And Company | External analgesic compositions |
US4702916A (en) | 1985-12-03 | 1987-10-27 | Warner-Lambert Company | Analgesic stick compositions |
USRE37934E1 (en) * | 1986-08-28 | 2002-12-10 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system |
US4863970A (en) * | 1986-11-14 | 1989-09-05 | Theratech, Inc. | Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols |
EP0347000B1 (en) * | 1988-06-17 | 1994-10-26 | The Procter & Gamble Company | The use of vanilloids for the manufacture of a medicament for treating herpes simplex infections |
US5028535A (en) * | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
ES2127729T3 (es) | 1990-08-29 | 1999-05-01 | Us Health | Alimento para aves que contiene capsaicina o sus derivados o analogos. |
WO1992009285A1 (en) | 1990-11-27 | 1992-06-11 | The Procter & Gamble Company | Combinations of vanilloid compounds and phosphonate antiviral compounds for treatment of herpes infections |
US5221692A (en) * | 1991-08-22 | 1993-06-22 | National Science Council | Ether linked and relatively nonpungent analogues of N-nonanoyl vanillylamide |
US5985860A (en) * | 1992-06-03 | 1999-11-16 | Toppo; Frank | System for transdermal delivery of pain relieving substances |
CA2114968A1 (en) | 1993-02-25 | 1994-08-26 | John Wille | Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
FR2722652B1 (fr) * | 1994-07-22 | 1997-12-19 | Rhone Poulenc Agrochimie | Composition fongicide comprenant une 2-imidazoline-5-one |
US5665378A (en) * | 1994-09-30 | 1997-09-09 | Davis; Roosevelt | Transdermal therapeutic formulation |
US5505958A (en) | 1994-10-31 | 1996-04-09 | Algos Pharmaceutical Corporation | Transdermal drug delivery device and method for its manufacture |
US5756107A (en) * | 1994-12-21 | 1998-05-26 | Cosmederm Technologies | Formulations and methods for reducing skin irritation |
DE69530062T2 (de) * | 1995-01-24 | 2004-02-05 | Defense Technology Corp. of America (n.d.Ges.d. Staates Delaware) | "Capsaicinoid" enthaltendes Tränengas |
US5654337A (en) * | 1995-03-24 | 1997-08-05 | II William Scott Snyder | Topical formulation for local delivery of a pharmaceutically active agent |
US5762963A (en) | 1995-06-07 | 1998-06-09 | Emory University | Method and compositions for controlling oral and pharyngeal pain using capsaicinoids |
US5716643A (en) | 1995-06-07 | 1998-02-10 | Hemosphere Inc. | Large scale production of medicine coated crosslinked protein microspheres |
US5882663A (en) * | 1995-10-20 | 1999-03-16 | Koeniger; Erich A. | Topical pain-relieving preparation containing C12 To C18 isoparaffins |
US6239180B1 (en) * | 1995-11-08 | 2001-05-29 | The Regents Of The University Of California | Transdermal therapeutic device and method with capsaicin and capsaicin analogs |
US6248788B1 (en) * | 1996-11-06 | 2001-06-19 | The Regents Of The University Of California | Therapeutic method with capsaicin and capasicin analogs |
CH690023A5 (de) * | 1996-02-02 | 2000-03-31 | Medichemie Ag | Mittel zur Behandlung krankhafter Zellveränderungen der Nasenschleimhaut. |
AUPN814496A0 (en) * | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
US5869533A (en) * | 1996-04-23 | 1999-02-09 | Holt; Stephen D. | Non-irritating capsaicin formulations and applicators therefor |
AU4045097A (en) | 1996-07-23 | 1998-02-10 | Wilson T. Crandall | Transdermal transport of molecules |
JP2001515492A (ja) | 1997-03-13 | 2001-09-18 | エヌ. キャンベル,ジェイムズ | カプサイシンまたはカプサイシンアナログを含有する組成物および局所麻酔 |
WO1998053825A1 (en) | 1997-05-27 | 1998-12-03 | Algos Pharmaceutical Corporation | Analgesic drug composition containing a capsaicinoid and potentiator therefor |
US5968539A (en) * | 1997-06-04 | 1999-10-19 | Procter & Gamble Company | Mild, rinse-off antimicrobial liquid cleansing compositions which provide residual benefit versus gram negative bacteria |
JP2002503254A (ja) | 1997-06-05 | 2002-01-29 | ヘモスフィア,インコーポレイテッド | フィブリノゲンをコーティングしたミクロスフィア |
US6013270A (en) | 1998-04-20 | 2000-01-11 | The Procter & Gamble Company | Skin care kit |
US6103266A (en) * | 1998-04-22 | 2000-08-15 | Tapolsky; Gilles H. | Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues |
JP4043605B2 (ja) * | 1998-07-02 | 2008-02-06 | 丸善製薬株式会社 | カプサイシン類縁体の製造法 |
ATE399565T1 (de) * | 1998-07-07 | 2008-07-15 | Transdermal Technologies Inc | Zusammensetzungen für die schnelle und nicht- irritierende transdermale verabreichung von pharmazeutika and verfahren zur formuliering davon und ihren verabreichung |
US6946144B1 (en) * | 1998-07-08 | 2005-09-20 | Oryxe | Transdermal delivery system |
GB2340751B (en) * | 1998-08-12 | 2003-11-05 | Edko Trading Representation | Pharmaceutical compositions |
JP3211027B2 (ja) * | 1998-11-13 | 2001-09-25 | 丸石製薬株式会社 | カプサイシン含有外用剤 |
JP2000143513A (ja) * | 1998-11-16 | 2000-05-23 | Taisho Pharmaceut Co Ltd | 外用組成物 |
US6390291B1 (en) | 1998-12-18 | 2002-05-21 | Smithkline Beecham Corporation | Method and package for storing a pressurized container containing a drug |
US6476076B1 (en) | 1999-02-22 | 2002-11-05 | Pacific Corporation | Vanilloid analogues containing resinferatoxin pharmacophores as potent vanilloid receptor agonists and analgesics, compositions and uses thereof |
US6294192B1 (en) | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
US6383471B1 (en) | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
US6277401B1 (en) | 1999-05-07 | 2001-08-21 | U.S. Dermatologics, Inc. | Drug delivery device |
US6299902B1 (en) * | 1999-05-19 | 2001-10-09 | The University Of Georgia Research Foundation, Inc. | Enhanced transdermal anesthesia of local anesthetic agents |
US6762158B2 (en) * | 1999-07-01 | 2004-07-13 | Johnson & Johnson Consumer Companies, Inc. | Personal care compositions comprising liquid ester mixtures |
US6348501B1 (en) * | 1999-09-29 | 2002-02-19 | Medical Merchandising, Inc. | Lotion compositions utilizing capsaicin |
JP2001114677A (ja) | 1999-10-13 | 2001-04-24 | Health Science Center:Kk | 皮膚塗布組成物 |
JP2001213772A (ja) | 2000-01-28 | 2001-08-07 | Health Science Center:Kk | 皮膚塗布剤組成物 |
JP4323797B2 (ja) * | 2000-07-07 | 2009-09-02 | エイ.ブイ.トップチーブ インスティテュート オブ ペトロケミカル シンセシス | 最適化した接着特性を有する親水性感圧接着剤の調製 |
IL137559A (en) * | 2000-07-27 | 2006-12-31 | Amnon Sintov | A system for administering drugs through the skin |
US6638981B2 (en) | 2001-08-17 | 2003-10-28 | Epicept Corporation | Topical compositions and methods for treating pain |
JP2003095983A (ja) * | 2001-09-21 | 2003-04-03 | Lion Corp | 皮膚外用剤組成物 |
JP2003095985A (ja) * | 2001-09-26 | 2003-04-03 | Lion Corp | 血行促進組成物 |
US20030104085A1 (en) * | 2001-12-05 | 2003-06-05 | Yeomans David C. | Methods and compositions for treating back pain |
US6819052B2 (en) * | 2002-05-31 | 2004-11-16 | Nagano Japan Radio Co., Ltd. | Coaxial type impedance matching device and impedance detecting method for plasma generation |
EP1539124B1 (en) | 2002-09-05 | 2018-07-18 | Vanderbilt Royalty Sub L.P. | Compositions and kits for the removal of irritating compounds from bodily surfaces |
US20040126415A1 (en) * | 2002-11-21 | 2004-07-01 | Lu Guang Wei | Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor |
JP4467437B2 (ja) | 2002-11-27 | 2010-05-26 | 久光製薬株式会社 | 温感パップ剤 |
AU2004230915B2 (en) | 2003-04-08 | 2008-08-07 | Algorx Pharmaceuticals, Inc. | Preparation and purification of synthetic capsaicin |
US7943166B2 (en) * | 2003-04-10 | 2011-05-17 | Neurogesx, Inc. | Methods and compositions for administration of TRPV1 agonists |
PL219512B1 (pl) * | 2003-04-14 | 2015-05-29 | Lohmann Therapie Syst Lts | Plaster miejscowy, zastosowanie plastra miejscowego i sposób wytwarzania plastra miejscowego |
US20070269379A1 (en) | 2003-07-23 | 2007-11-22 | Samir Mitragotri | Penetration Enhancer Combinations for Transdermal Delivery |
PT1670433E (pt) | 2003-10-10 | 2012-02-08 | Ferring Bv | Fórmula farmacológica transdérmica para a minimização de resíduos na pele |
US7244446B2 (en) * | 2003-10-16 | 2007-07-17 | Winston Laboratories, Inc. | Method for providing long-lasting pain diminishment through topical or intranasal administration of civamide |
ZA200707492B (en) | 2005-02-14 | 2009-02-25 | Neurogesx Inc | Device for delivery of TRPV1 agonists |
US20060222690A1 (en) * | 2005-03-30 | 2006-10-05 | Bley Keith R | Low-concentration capsaicin patch and methods for treating neuropathic pain |
-
2004
- 2004-04-12 US US10/823,426 patent/US7943166B2/en active Active
- 2004-04-12 WO PCT/US2004/011336 patent/WO2004091521A2/en active Application Filing
- 2004-04-12 EA EA200501592A patent/EA012599B1/ru not_active IP Right Cessation
- 2004-04-12 EP EP14198000.3A patent/EP2907503A1/en not_active Withdrawn
- 2004-04-12 CA CA2522028A patent/CA2522028C/en not_active Expired - Lifetime
- 2004-04-12 ES ES04750050.9T patent/ES2535045T3/es not_active Expired - Lifetime
- 2004-04-12 JP JP2006509964A patent/JP4931128B2/ja not_active Expired - Lifetime
- 2004-04-12 EP EP04750050.9A patent/EP1610742B1/en not_active Expired - Lifetime
-
2006
- 2006-07-03 HK HK06107501.1A patent/HK1085643A1/xx not_active IP Right Cessation
-
2010
- 2010-05-19 JP JP2010115835A patent/JP2010174046A/ja not_active Withdrawn
-
2011
- 2011-04-08 US US13/083,306 patent/US8263093B2/en not_active Expired - Lifetime
- 2011-04-08 US US13/083,294 patent/US8273390B2/en not_active Expired - Lifetime
-
2012
- 2012-08-14 US US13/585,692 patent/US8734770B2/en not_active Expired - Lifetime
- 2012-12-20 JP JP2012278005A patent/JP5668046B2/ja not_active Expired - Lifetime
-
2014
- 2014-04-17 US US14/255,630 patent/US9750707B2/en not_active Expired - Lifetime
- 2014-08-25 JP JP2014170136A patent/JP2014240415A/ja not_active Withdrawn
-
2016
- 2016-02-19 HK HK16101869.8A patent/HK1213802A1/zh unknown
- 2016-10-31 JP JP2016212757A patent/JP2017019870A/ja not_active Withdrawn
-
2017
- 2017-08-01 US US15/666,413 patent/US10653647B2/en not_active Expired - Lifetime
-
2018
- 2018-12-21 JP JP2018238994A patent/JP2019043962A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US20150073056A1 (en) | 2015-03-12 |
US8734770B2 (en) | 2014-05-27 |
JP2019043962A (ja) | 2019-03-22 |
WO2004091521A3 (en) | 2005-03-03 |
US20180169039A1 (en) | 2018-06-21 |
EP1610742B1 (en) | 2015-01-21 |
EP1610742A2 (en) | 2006-01-04 |
JP2006522832A (ja) | 2006-10-05 |
ES2535045T3 (es) | 2015-05-04 |
US8273390B2 (en) | 2012-09-25 |
US9750707B2 (en) | 2017-09-05 |
US10653647B2 (en) | 2020-05-19 |
EA200501592A1 (ru) | 2006-06-30 |
EP2907503A1 (en) | 2015-08-19 |
JP2013060461A (ja) | 2013-04-04 |
HK1213802A1 (zh) | 2016-07-15 |
US7943166B2 (en) | 2011-05-17 |
JP2010174046A (ja) | 2010-08-12 |
US20110184069A1 (en) | 2011-07-28 |
EA012599B1 (ru) | 2009-10-30 |
US20050090557A1 (en) | 2005-04-28 |
JP2014240415A (ja) | 2014-12-25 |
EP1610742A4 (en) | 2011-07-27 |
JP2017019870A (ja) | 2017-01-26 |
CA2522028A1 (en) | 2004-10-28 |
US20120309836A1 (en) | 2012-12-06 |
WO2004091521A2 (en) | 2004-10-28 |
JP4931128B2 (ja) | 2012-05-16 |
CA2522028C (en) | 2011-11-01 |
US8263093B2 (en) | 2012-09-11 |
JP5668046B2 (ja) | 2015-02-12 |
US20110196043A1 (en) | 2011-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1085643A1 (en) | Uses and compositions for administration of capsaicin | |
IL197889A (en) | Pyridylvinylazacyclopentane compound and pharmaceutical compositions comprising same | |
TWI340138B (en) | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | |
IL179250A0 (en) | Stable crystal of 4-oxoquinoline compound and pharmaceutical compositions containing the same | |
IL173930A0 (en) | Pharmaceutical compositions containing forms of r-baclofen | |
GB0321607D0 (en) | Manufacture of pharmaceutical compositions | |
IL173726A (en) | Pharmaceutical compositions containing n-n-dihaloamino acids and their uses | |
IL178297A0 (en) | Hydrazide derivatives and pharmaceutical compositions containing the same | |
IL173639A0 (en) | Ppar-activating compound and pharmaceutical composition containing same | |
IL177168A0 (en) | N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same | |
IL170313A (en) | Diarylcycloalkyl derivatives and pharmaceutical compositions comprising them | |
ZA200703713B (en) | Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof | |
EP1587482A4 (en) | ANTI-INFLAMMATORY COMPOSITIONS AND USES THEREOF | |
IL221323A0 (en) | 1-methyl-1h- pyridin-2-one- phenanthridine derivatives and pharmaceutical compositions containing the same | |
EP1654380A4 (en) | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING HEPARANASE ACTIVATION AND USES THEREOF | |
IL174591A0 (en) | Composition and dosage form for sustained effect of levodopa | |
EP1680109A4 (en) | AMIDE DERIVATIVES AS ION CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE DERIVATIVES | |
IL183986A0 (en) | Pharmaceutical compounds and compositions | |
IL182126A (en) | Preparations containing and used in the history of 5-phenoxyalkoxypsoralen | |
IL166621A0 (en) | Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same | |
IL176077A0 (en) | 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them | |
IL181730A0 (en) | Benzodiazinone derivatives and pharmaceutical compositions containing the same | |
IL177498A0 (en) | Difluoroethoxy -substituted hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same | |
HK1109576A1 (en) | Aequorin-containing compositions and methods of using same | |
IL177497A0 (en) | Isoamido-substituted hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE | Patent expired |
Effective date: 20240411 |